Chimeric Antigen Receptor (CAR)-T cell therapy is a therapeutic approach whereby T-cells are engineered with a synthetic receptor for increased tumor targeting specificity and tumor cytotoxicity.
Novel dual CAR approach is designed to enhance CAR T-cell activity in solid tumors by addressing immune suppression in the tumor microenvironment LOS ANGELES, April 22, 2024 /PRNewswire/ -- ImmPACT ...
IMPT-601 is designed to overcome the suppressive tumor microenvironment by enhancing CAR T- cell infiltration, overcoming T-cell exhaustion, and reducing regulatory T-cell activity LOS ANGELES, Oct.
Novel dual CAR approach is designed to enhance CAR T-cell activity in solid tumors by addressing immune suppression in the tumor microenvironment "There is a significant unmet medical need in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results